Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 10/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29124814 | 0.83 | BTK (0.46) | BTKEPHX2SMN1; SMN2 | |
| SCHEMBL29124728 | 0.83 | BTK (0.53) | BTKEPHX2 | |
| SCHEMBL29124637 | 0.83 | BTK (0.41) | BTKEPHX2 | |
| SCHEMBL29124777 | 0.80 | BTK (0.39) | BTKEPHX2 | |
| SCHEMBL29124649 | 0.79 | BTK (0.53) | BTKEPHX2LMNA | |
| SCHEMBL25245236 | 0.77 | BTK (0.51) | BTKALDH1A1MAPK1EPHX2NPC1 | |
| SCHEMBL29124756 | 0.76 | KLKB1 (0.44) | BTKEPHX2 | |
| SCHEMBL22659381 | 0.74 | BTK (0.52) | BTK | |
| SCHEMBL29533029 | 0.74 | BTK (0.52) | BTK | |
| SCHEMBL25249865 | 0.71 | BTK (0.47) | BTKALDH1A1MAPK1EPHX2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116917279-A | BTK inhibitors | 渤健马萨诸塞州股份有限公司 | 2023-10-20 | — | — | CN | disclosed |